Publication:
Differential expressions of estrogen and progesterone receptors in endometria and cyst walls of ovarian endometrioma from women with endometriosis and their responses to depo-medroxyprogesterone acetate treatment

dc.contributor.authorMorakot Sroyrayaen_US
dc.contributor.authorSineenart Songkoomkrongen_US
dc.contributor.authorNarin Changklungmoaen_US
dc.contributor.authorJaruwan Poljaroenen_US
dc.contributor.authorSawaek Weerakieten_US
dc.contributor.authorAreepan Sophonsritsuken_US
dc.contributor.authorAnna Wongkularben_US
dc.contributor.authorSrithean Lertvikoolen_US
dc.contributor.authorYada Tingthanatikulen_US
dc.contributor.authorPrasert Sobhonen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherBurapha Universityen_US
dc.date.accessioned2019-08-23T10:30:05Z
dc.date.available2019-08-23T10:30:05Z
dc.date.issued2018-08-01en_US
dc.description.abstract© 2018 Elsevier Ltd Background: Depo-medroxyprogesterone acetate (DMPA) is an injectable progestin contraceptive that provides a highly effective reduction of pelvic pain in women with endometriosis. Despite its wide use to treat pain associated with endometriosis, its precise mechanisms of action remain unclear. The aims of this study were to investigate the differential expressions of estrogen receptors (ERs), and progesterone receptors (PRs) in endometria and ovarian endometrioma cyst walls of women with endometriosis with and without DMPA treatment. Methods: Endometria and cyst walls of endometrioma were obtained from 25 to 45 year-old women who suffered from endometriosis and had ovarian endometrioma with the size ≥3 cm. The expression levels of ERs and PRs and the numbers of ER- and PR-positive cells before and after treatment with DMPA were evaluated by Western blot, real-time PCR, and immunohistochemistry. Results: The levels of ERα and ERβ expression, their corresponding mRNAs, and numbers of ERα- and ERβ-immunoreactive cells in stroma and glands of endometria of the DMPA group were significantly decreased when compared with those of the untreated groups (p < 0.05). In contrast, the levels of PRA/B expression and numbers of PRA/B positive cells in stroma and number of PRB positive cells in stroma and endometrial glands were significantly increased in endometria of the DMPA group when compared with those of the untreated groups. However, in cyst wall the expression levels of these proteins, their corresponding mRNAs, and immonoractive cells were low compared to those in endometria, and DMPA-treatment did not cause any significant changes in these parameters. Conclusion: These data indicated that DMPA could upregulate the expressions of PRA/B and down-regulate ERα and ERβ in endometria but not in cyst walls from women with endometriosis.en_US
dc.identifier.citationMolecular and Cellular Probes. Vol.40, (2018), 27-36en_US
dc.identifier.doi10.1016/j.mcp.2018.07.001en_US
dc.identifier.issn10961194en_US
dc.identifier.issn08908508en_US
dc.identifier.other2-s2.0-85049556196en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/45096
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049556196&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleDifferential expressions of estrogen and progesterone receptors in endometria and cyst walls of ovarian endometrioma from women with endometriosis and their responses to depo-medroxyprogesterone acetate treatmenten_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049556196&origin=inwarden_US

Files

Collections